Roles of Multidrug Resistance Protein 4 in Microbial Infections and Inflammatory Diseases

Area of Science:

• Pharmacology
• Microbiology
• Immunology

Background:

• Antimicrobial resistance (AMR) is a growing global health threat, leading to treatment failures and increased mortality.
• Multidrug resistance proteins (MRPs), especially MRP4 (ABCC4), are implicated in the efflux of antimicrobial drugs, contributing to AMR.
• The precise mechanisms of MRP4's role in AMR and inflammatory conditions require further elucidation.

Purpose of the Study:

• To review the function, regulation, and involvement of MRP4 in microbial infections and inflammatory diseases.
• To highlight the potential of targeting MRP4 as a therapeutic strategy against AMR and inflammation.
• To discuss the impact of genetic polymorphisms in the MRP4 gene.

Main Methods:

• Literature review of studies on MRP4 function, regulation, and its role in disease.
• Synthesis of current knowledge on MRP4's involvement in antimicrobial resistance mechanisms.
• Analysis of research on MRP4 in the context of inflammatory diseases.

Main Results:

• MRP4 acts as a drug efflux pump, significantly contributing to multidrug resistance (MDR) in various infections.
• MRP4 plays a role in modulating inflammatory responses, suggesting a dual function in infection and immunity.
• Genetic variations in the MRP4 gene may influence individual susceptibility and treatment outcomes.

Conclusions:

• MRP4 is a critical factor in the development of antimicrobial resistance and influences inflammatory processes.
• Suppression of MRP4 presents a promising therapeutic avenue for enhancing antimicrobial efficacy and managing inflammatory diseases.
• Further research into MRP4-targeted therapies is warranted to combat MDR and inflammatory conditions effectively.